Robert F. Kennedy Jr. flew off the handle after this bombshell study exposed the true dangers of this popular pharmaceutical

Robert F. Kennedy Jr., Photo by Gage Skidmore via Wikimedia, CC BY-SA 2.0, https://creativecommons.org/licenses/by-sa/2.0/deed.en

The American medical system is a racket. 

Big Pharma’s stranglehold over us will be a main target of the Trump administration. 

And Robert F. Kennedy Jr. flew off the handle after this bombshell study exposed the true dangers of this popular pharmaceutical.

Prozac is a frequently prescribed selective serotonin reuptake inhibitor (SSRIs) for individuals struggling with depression.

According to Mercola.com, “The International Journal of Risk & Safety in Medicine study revealed biased outcomes favoring fluoxetine, the generic name for Prozac, and missing reports of suicidal events. Such discrepancies question the reliability of the published data and highlight the need for accurate reporting in medical literature.”

How could a study on antidepressants not explicitly show “suicidal events?” 

That should be the first topic since we’d all want to know if a psychiatric drug made suicide more or less likely?

But no one can make an informed choice with information being hidden. 

Beyond the risks of the drug, the safety study showed an effectiveness rate of a measly 4%, which is considered clinically insignificant. 

That means it doesn’t work. 

In other words, there is almost no upside to taking the drug, but there are serious risks.  

In addition to psychological problems, the drug caused participants to lose physical mass, both weight and height, during the 19 week trial. 

The results of this safety study raise some alarming questions about previous studies, which deemed Prozac “safe and effective.”

According to the UK’s National Health Service, “Fluoxetine (generic Prozac) is safe to take for a long time. A few people may get sexual side effects, such as problems getting an erection or a lower sex drive.”

That doesn’t seem to be so bad, but the Mayo Clinic website shows more possible side effects. 

https://www.mayoclinic.org/drugs-supplements/fluoxetine-oral-route/description/drg-20063952

The common ones are itchy skin and restlessness. 

Less common are chills and fever and joint or muscle pains. 

Under “rare” are listed twenty-five different conditions ranging from seizures to dry mouth to drowsiness. 

But suicide is not listed. 

Of course, it can’t be listed if the data is hidden. How could the Mayo Clinic know to list that possible side effect without a truthful study?

Naturally, Big Pharma companies don’t want their customers or potential customers to worry that taking their medication may cause them to kill themselves. 

That’s why we are supposed to have rigid, thorough and independent studies to prevent the obvious biases and conflicts of interest. 

Robert F. Kennedy Jr. has been nominated to head the Health and Human Services, which oversees the FDA and is supposed to protect Americans from Big Pharma. 

But Kennedy threw the gauntlet down, so to speak.

“FDA’s war on public health is about to end,” Kennedy posted on X in late October. “If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags.”

One target will likely be the revolving door between FDA and Big Pharma. 

Many people who work for the FDA get hired by Big Pharma companies right after they leave, and presumably, make a lot more money. 

Knowing this is their future, FDA employees have an enormous incentive to grease the skids and remove roadblocks for their future employers. 

Then there’s the issue of Big Pharma companies funding the research that gets their products approved. 

According to an article in the Scientific American, “In 2007, researchers looked at every published trial that set out to explore the benefit of a statin. These are cholesterol lowering drugs which reduce your risk of having a heart attack, they are prescribed in very large quantities.”

“This study found 192 trials in total, either comparing one statin against another, or comparing a statin against a different kind of treatment,” the article added. “Once the researchers controlled for other factors . . . they found that industry-funded trials were twenty times more likely to give results favoring the test drug.”

Twenty-times more likely is a substantial, meaningful difference. 

There is lots of anxiety in the government bureaucracies as Trump is deploying disruptors to fix our broken system. 

So the FDA Commissioner sent an email to calm their nerves.  

 “There will, no doubt, be changes ahead, but rest assured, the FDA will continue to do the job it was created to do,” he wrote in an email viewed by Reuters. “The work you do will remain critical and this agency will continue to protect the public, as it has for over a century.”